Prestige Consumer Healthcare Inc. (PBH)
After hours:
| Previous Close | 65.44 |
| Open | 64.87 |
| Bid | 0.00 x 1000 |
| Ask | 0.00 x 800 |
| Day's Range | 64.26 - 65.87 |
| 52 Week Range | 56.25 - 75.31 |
| Volume | |
| Avg. Volume | 248,880 |
| Market Cap | 3.279B |
| Beta (5Y Monthly) | 0.50 |
| PE Ratio (TTM) | 15.75 |
| EPS (TTM) | 4.17 |
| Earnings Date | Aug 01, 2024 - Aug 05, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Dec 27, 2013 |
| 1y Target Est | 74.60 |
GlobeNewswirePrestige Consumer Healthcare Inc. to Present at the Oppenheimer Annual Consumer Growth and E-Commerce Conference
TARRYTOWN, N.Y., June 06, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced it will present at the Oppenheimer Annual Consumer Growth and E-Commerce Conference on Monday, June 10, 2024 at 1:30 p.m. ET. All interested parties may access a live webcast of this event at www.prestigeconsumerhealthcare.com under the "Investors” section and the "Events and Presentations" tab, or by using the following link: https://ir.prestigebrands.com/events-presentations/events F
- GuruFocus.com
Prestige Consumer Healthcare Inc (PBH) (Q4 2024) Earnings Call Transcript Highlights: ...
Despite flat year-over-year revenue and supply chain hurdles, PBH achieves significant deleveraging and projects optimistic fiscal '25 outlook.
- GlobeNewswire
Prestige Consumer Healthcare Inc. Reports Fiscal Year 2024 Results
Revenue of $277.0 Million in Q4 and $1,125.4 Million in Fiscal 2024Solid Consumption Trends in Q4 Offset by Near-Term Supply Chain ConstraintsAchieved Leverage Ratio of 2.8x at Year-End, Below Long-Term TargetBoard of Directors Authorize New $300 Million Share Repurchase ProgramInitial Full-Year Fiscal 2025 Organic Revenue Growth and EPS Outlook of Approximately 1% and $4.40 to $4.46, respectively TARRYTOWN, N.Y., May 14, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) toda
